Management of CMPA in infancy: current approaches and future perspective
Abstract
and severity in recent years.The objective of this study is to review the methods of CMPA diagnosis March."A comprehensive review of existing guidelines for CMPA diagnosis and treatment was conducted, with a focus on allergen avoidance and nutritional optimization through hypoallergenic Bifidobacterium lactis Bb-12, in expediting tolerance development was explored.Additionally, the potential of butyrate in modulating immune responses was examined and the impact of hypoallergenic formulas with probiotics, such as LGG was studied, in reducing other allergic manifestations and FGIDs.Studies assessing the preventive measures to curb the progression of FGIDs in CMPA children were also reviewed.This study signifies the achievement of immune tolerance in CMPA management.While some studies suggest a positive impact of probiotics on tolerance development, controversies exist, thus necessitating further research.Nutritional butyrate in modulating immune responses and mitigating food allergies is promising.Additionally, hypoallergenic formulas with probiotics may reduce the incidence of other allergic manifestations the progression of FGIDs in CMPA children.
Fields of Study & Subjects
Metabolism and Genetic Disorders
Neonatal Health and Biochemistry
Complement system in diseases
Publication details
- Publication date
- 1 January 2026
- Language
- EN